Grade 2 Glioma (Astrocytoma or Oligodendroglioma) With an IDH1 Mutation

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Grade 2 Glioma (Astrocytoma or Oligodendroglioma) With an IDH1 Mutation trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 3

NCT07712757

Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant Glioma

This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter study comparing the efficacy and safety of safusidenib versus placebo in participan…

Location not specified140 participantsStarted 2027-03Updated 2026-07-17

Treatment: Safusidenib, Placebo